pharmaphorum

JULY 4, 2024

Pieris' immuno-oncology alliance with Servier is being dissolved after a trial of the lead drug in the alliance revealed a safety concern.

Trials 69

Trials Drugs 69

Drug Patent Watch

JULY 4, 2024

Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.

Drugs 59

Drugs Branding Marketing 59

Pharma Times

JULY 4, 2024

Aggressive prostate cancer accounts for up to 15% of all prostate cancer diagnoses

Genetics 82

Genetics Research 82

pharmaphorum

JULY 4, 2024

UK survey finds more than two-thirds of people with chronic hand eczema say it has affected their relationships and/or working life.

64

64

Advertisement

Clinical Supply

Pharma Times

JULY 4, 2024

In the UK, the progressive neurodegenerative condition affects around 153,000 people

77

77

Drug Discovery World

JULY 4, 2024

A new whitepaper is now available to download for free from Bruntwood SciTech. This whitepaper, Fuelling the future: Precision medicine innovation and the role of ecosystems , examines how the future of drug discovery and precision medicine can be enhanced by life science ecosystems such as those created by the UK’s leading property developer to the science and technology sectors, Bruntwood SciTech.

Medicine 52

Medicine Life Science Drugs Development 52

pharmaphorum

JULY 4, 2024

Changing Faces explores the digital and supplier hires from April 2024, with a focus on companies like SPT Labtech, Sphere Fluidics, Newel Health, and Diaceutics. Stay updated on the latest developments in the industry.

Development 52

Development 52

XTalks

JULY 4, 2024

Oral health disparities continue to impact underserved communities around the world. These disparities stem from multiple barriers, including the cost of care, accessibility and low health literacy. In this interview, we explore how industry leaders are tackling these challenges to improve global oral health. Xtalks spoke to Dr. Maria Ryan, executive vice president and chief clinical officer at Colgate-Palmolive, and Allison Neale, vice president of Public Policy at Henry Schein, Inc. and manag

Medicine 52

Medicine Research Production Nurses 52

Outsourcing Pharma

JULY 4, 2024

CatSci, a UK-based innovation partner for the development of pharmaceutical manufacturing processes, will be expanding its service offering with the acquisition of Reach Separations.

Manufacturing 52

Manufacturing Development Regulation Marketing 52

XTalks

JULY 4, 2024

Nestlé Health Science recently introduced an innovative platform, GLP-1 Nutrition. The newly launched website is designed to provide comprehensive nutritional support for individuals on their weight management journey, including those using glucagon-like peptide-1 (GLP-1) medications. In this episode of the Xtalks Food Podcast, Sydney talks about the platform, which serves as a comprehensive hub for individuals on a weight management journey.

Production 52

Production Marketing Drugs 52

Advertisement

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

Clinical Trials

Outsourcing Pharma

JULY 4, 2024

Preclinical results show promise for Tyra Bioscienceâs lead drug candidate for the treatment for hypochondroplasia, a condition for which there are currently no therapeutic options available.

Drugs 52

Drugs Clinical Development Development 52

BioPharma Reporter

JULY 4, 2024

RNA therapeutics have emerged as a transformative approach to treating many conditions, but the industry still typically relies on inefficient batch manufacturing methods.

RNA 52

RNA Manufacturing Gene Therapy Gene 52

pharmaphorum

JULY 4, 2024

AI developed by Pangea Biomed predicts the chances that a patient will respond to cancer treatment by looking at tumour images.

Development 59

Development 59

BioPharma Reporter

JULY 4, 2024

Eli Lilly has finally achieved FDA approval for its monoclonal antibody Alzheimerâs therapy donanemab, bringing new competition to the field for Eisai and Biogen.

FDA Approval 52

FDA Approval Antibody Development 52

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials

pharmaphorum

JULY 4, 2024

A Connecticut federal judge has rejected Boehringer Ingelheim's challenge to Medicare’s drug price negotiation programme.

Drugs 63

Drugs 63

Pharmaceutical Commerce

JULY 4, 2024

The investment is expected to help enhance the company temperature-controlled services in the Netherlands, France Italy, and Hungary.

52

52

pharmaphorum

JULY 4, 2024

The US government has signed a $176 million deal with Moderna to develop an mRNA-based pandemic influenza vaccine.

Vaccination 59

Vaccination Vaccine Development 59

Outsourcing Pharma

JULY 4, 2024

Under the terms of the agreement, Eli Lilly will obtain the exclusive rights to acquire Radionetics Oncology for $1 billion.

Regulation 52

Regulation Marketing 52

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

Clinical Research

Drug Discovery World

JULY 4, 2024

This whitepaper, Fuelling the future: Precision medicine innovation and the role of ecosystems , examines how the future of drug discovery and precision medicine can be enhanced by life science ecosystems such as those created by the UK’s leading property developer to the science and technology sectors, Bruntwood SciTech. In the whitepaper, you will discover: The evolution of precision diagnostics for oncology in the North West of England How life science ecosystems enable key breakthroug

Medicine 40

Medicine Life Science Drugs Development 40

XTalks

JULY 4, 2024

The pharma industry is poised for significant transformations in 2024, driven by groundbreaking drugs that have set new benchmarks in the industry. This blog delves into the top 30 drugs to watch in 2024, leveraging insights from their sales performance in 2023. These medications have not only redefined therapeutic standards across various medical conditions but have also showcased impressive sales figures, innovative advancements and expanded indications.

Sales 52

Sales Drugs FDA Approval Marketing 52

BioPharma Reporter

JULY 4, 2024

CAR-T therapies have big potential to take on blood cancer but also have major drawbacks.

Development 52

Development 52

Pharmaceutical Commerce

JULY 4, 2024

The latest news for pharma industry insiders.

FDA Approval 52

FDA Approval 52

Advertiser: FourKites

A research study conducted by The Journal of Commerce and FourKites surveyed hundreds of international shippers, exploring how their usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19. For international shippers, ocean freight visibility has evolved from optional to essential and satisfaction with visibility varies greatly depending on how it is obtained and delivered.

Research

Drug Patent Watch

JULY 4, 2024

This chart shows the pharmaceutical companies with the most gas dosed drugs. For a different perspective, see the most popular dosage types.

Drugs 59

Drugs 59